Low dose enzalutamide in metastatic castration-resistant prostate cancer: A retrospective Caribbean study.

Vincent Vinh-Hung,Kadiatou Diakité,Clarisse Joachim,Stefanos Bougas,Cristina Ioana Furtos,Jean Marc Rakotonarivo,Wadah Lababidi,Eva Papadopoulou,P. Escarmant,Jacqueline Veronique-Baudin,Claire F. Verschraegen

Low dose enzalutamide in metastatic castration-resistant prostate cancer: A retrospective Caribbean study.

2019

Vincent Vinh-Hung
Kadiatou Diakité
Clarisse Joachim
Stefanos Bougas
Cristina Ioana Furtos
Jean Marc Rakotonarivo
Wadah Lababidi
Eva Papadopoulou
P. Escarmant
Jacqueline Veronique-Baudin
Claire F. Verschraegen

e16548Background: There is scarce information on the efficacy of low-dose enzalutamide in metastatic castration-resistant prostate cancer. We report on a series treated with half dose enzalutamide....

Keywords:

Prostate cancer
Castration
Oncology
Pathology
Medicine
Internal medicine
Enzalutamide
castration resistant
low dose

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations